|
1
|
Payet CA, You A, Fayet OM, Dragin N,
Berrih-Aknin S and Le Panse R: Myasthenia gravis: An acquired
interferonopathy? Cells. 11:12182022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gilhus NE, Tzartos S, Evoli A, Palace J,
Burns TM and Verschuuren J: Myasthenia gravis. Nat Rev Dis Primers.
5:302019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huijbers MG, Marx A, Plomp JJ, Le Panse R
and Phillips WD: Advances in the understanding of disease
mechanisms of autoimmune neuromuscular junction disorders. Lancet
Neurol. 21:163–175. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cortés-Vicente E, Álvarez-Velasco R,
Segovia S, Paradas C, Casasnovas C, Guerrero-Sola A, Pardo J,
Ramos-Fransi A, Sevilla T, López de Munain A, et al: Clinical and
therapeutic features of myasthenia gravis in adults based on age at
onset. Neurology. 94:e1171–e1180. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gilhus NE and Verschuuren JJ: Myasthenia
gravis: Subgroup classification and therapeutic strategies. Lancet
Neurol. 14:1023–1036. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Punga AR, Maddison P, Heckmann JM, Guptill
JT and Evoli A: Epidemiology, diagnostics, and biomarkers of
autoimmune neuromuscular junction disorders. Lancet Neurol.
21:176–188. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
García Estévez DA and Pardo Fernández J:
Myasthenia gravis. Update on diagnosis and therapy. Med Clin
(Barc). 161:119–127. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mahic M, Bozorg A, DeCourcy J, Golden K,
Gibson G, Taylor C and Scowcroft A: Physician- and patient-reported
perspectives on myasthenia gravis in Europe: A real-world survey.
Orphanet J Rare Dis. 18:1692023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Petersson M, Feresiadou A, Jons D, Ilinca
A, Lundin F, Johansson R, Budzianowska A, Roos AK, Kågström V,
Gunnarsson M, et al: Patient-Reported symptom severity in a
nationwide myasthenia gravis cohort: Cross-sectional analysis of
the swedish GEMG study. Neurology. 97:e1382–1391. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Verschuuren JJ, Palace J, Murai H,
Tannemaat MR, Kaminski HJ and Bril V: Advances and ongoing research
in the treatment of autoimmune neuromuscular junction disorders.
Lancet Neurol. 21:189–202. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Walker BR and Moraes CT:
Nuclear-mitochondrial interactions. Biomolecules. 12:4272022.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
de Beauchamp L, Himonas E and Helgason GV:
Mitochondrial metabolism as a potential therapeutic target in
myeloid leukaemia. Leukemia. 36:1–12. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiang L, Shao Y and Chen Y: Mitochondrial
dysfunction and mitochondrion-targeted therapeutics in liver
diseases. J Drug Target. 29:1080–1093. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang X, Xue P, Yuan M, Xu X, Wang C, Li W,
Machens HG and Chen Z: SESN2 protects against denervated muscle
atrophy through unfolded protein response and mitophagy. Cell Death
Dis. 12:8052021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Martignago S, Fanin M, Albertini E,
Pegoraro E and Angelini C: Muscle histopathology in myasthenia
gravis with antibodies against MuSK and AChR. Neuropathol Appl
Neurobiol. 35:103–110. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shichijo K, Mitsui T, Kunishige M, Kuroda
Y, Masuda K and Matsumoto T: Involvement of mitochondria in
myasthenia gravis complicated with dermatomyositis and rheumatoid
arthritis: A case report. Acta Neuropathol. 109:539–542. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sousa-Soares C, Noronha-Matos JB and
Correia-de-Sá P: Purinergic tuning of the tripartite neuromuscular
synapse. Mol Neurobiol. 60:4084–4104. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ferrari R, Rodrigues-Simioni L and da Cruz
Höfling MA: Guanidine affects differentially the twitch response of
diaphragm, extensor digitorum longus and soleus nerve-muscle
preparations of mice. Molecules. 17:7503–7522. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiao W, Hu F, Li J, Song J, Liang J, Li L,
Song Y, Chen Z, Li Q and Ke L: Qiangji Jianli Decoction promotes
mitochondrial biogenesis in skeletal muscle of myasthenia gravis
rats via AMPK/PGC-1α signaling pathway. Biomed Pharmacother.
129:1104822020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ke L, Li Q, Song J, Jiao W, Ji A, Chen T,
Pan H and Song Y: The mitochondrial biogenesis signaling pathway is
a potential therapeutic target for myasthenia gravis via energy
metabolism (Review). Exp Ther Med. 22:7022021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li L, Cai D, Zhong H, Liu F, Jiang Q,
Liang J, Li P, Song Y, Ji A, Jiao W, et al: Mitochondrial dynamics
and biogenesis indicators may serve as potential biomarkers for
diagnosis of myasthenia gravis. Exp Ther Med. 23:3072022.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song J, Lei X, Jiao W, Song Y, Chen W, Li
J and Chen Z: Effect of Qiangji Jianli decoction on mitochondrial
respiratory chain activity and expression of mitochondrial fusion
and fission proteins in myasthenia gravis rats. Sci Rep.
8:86232018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng Z, Guo C, Li M, Yang L, Liu P, Zhang
X, Liu Y, Guo X, Cao S, Dong Y, et al: Hypothalamus-habenula
potentiation encodes chronic stress experience and drives
depression onset. Neuron. 110:1400–1415.e6. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Su L, Zhang J, Gomez H, Kellum JA and Peng
Z: Mitochondria ROS and mitophagy in acute kidney injury.
Autophagy. 19:401–414. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gupta R, Ambasta RK and Pravir K:
Autophagy and apoptosis cascade: Which is more prominent in
neuronal death? Cell Mol Life Sci. 78:8001–8047. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lai Y, Xu X, Zhu Z and Hua Z: Highly
efficient siRNA transfection in macrophages using apoptotic
body-mimic Ca-PS lipopolyplex. Int J Nanomedicine. 13:6603–6623.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Ma G, Guo Z, Yu Q, Han L, Han M
and Zhu Y: Study on the apoptosis mediated by
apoptosis-inducing-factor and influencing factors of bovine muscle
during postmortem aging. Food Chem. 266:359–367. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Piras A, Schiaffino L, Boido M, Valsecchi
V, Guglielmotto M, De Amicis E, Puyal J, Garcera A, Tamagno E,
Soler RM and Vercelli A: Inhibition of autophagy delays motoneuron
degeneration and extends lifespan in a mouse model of spinal
muscular atrophy. Cell Death Dis. 8:32232017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kuno A, Hosoda R, Sebori R, Hayashi T,
Sakuragi H, Tanabe M and Horio Y: Resveratrol ameliorates mitophagy
disturbance and improves cardiac pathophysiology of
Dystrophin-deficient mdx Mice. Sci Rep. 8:155552018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
De Palma C, Morisi F, Cheli S, Pambianco
S, Cappello V, Vezzoli M, Rovere-Querini P, Moggio M, Ripolone M,
Francolini M, et al: Autophagy as a new therapeutic target in
Duchenne muscular dystrophy. Cell Death Dis. 3:e4182012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bloemberg D and Quadrilatero J: Autophagy,
apoptosis, and mitochondria: Molecular integration and
physiological relevance in skeletal muscle. Am J Physiol Cell
Physiol. 317:C111–C130. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jing H, Xie R, Bai Y, Duan Y, Sun C, Wang
Y, Cao R, Ling Z and Qu X: The mechanism actions of astragaloside
IV prevents the progression of hypertensive heart disease based on
network pharmacology and experimental pharmacology. Front
Pharmacol. 12:7556532021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Song J, Li Q, Ke L, Liang J, Jiao W, Pan
H, Li Y, Du Q, Song Y, Ji A, et al: Qiangji jianli decoction
alleviates hydrogen peroxide-induced mitochondrial dysfunction via
regulating mitochondrial dynamics and biogenesis in L6 myoblasts.
Oxid Med Cell Longev. 2021:66606162021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Costa IM, Lima FOV, Fernandes LCB, Norrara
B, Neta FI, Alves RD, Cavalcanti JRLP, Lucena EES, Cavalcante JS,
Rego ACM, et al: Astragaloside IV supplementation promotes A
neuroprotective effect in experimental models of neurological
disorders: A systematic review. Curr Neuropharmacol. 17:648–665.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu T, Wang L, Wang LP and Wan Q:
Therapeutic targets of neuroprotection and neurorestoration in
ischemic stroke: Applications for natural compounds from medicinal
herbs. Biomed Pharmacother. 148:1127192022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhong Y, Liu W, Xiong Y, Li Y, Wan Q, Zhou
W, Zhao H, Xiao Q and Liu D: Astragaloside IV alleviates ulcerative
colitis by regulating the balance of Th17/Treg cells.
Phytomedicine. 104:1542872022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bolduc JA, Collins JA and Loeser RF:
Reactive oxygen species, aging and articular cartilage homeostasis.
Free Radic Biol Med. 132:73–82. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jiang B, Yang YJ, Dang WZ, Li H, Feng GZ,
Yu XC, Shen XY and Hu XG: Astragaloside IV reverses
simvastatin-induced skeletal muscle injury by activating the
AMPK-PGC-1α signalling pathway. Phytother Res. 34:1175–1184. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals, . Guide for the care and use of laboratory animals. 8th
edition. Washington (DC): National Academies Press (US); 2011
|
|
40
|
Baggi F, Annoni A, Ubiali F, Longhi R,
Milani M, Mantegazza R, Cornelio F and Antozzi C: Immunization with
rat-, but not Torpedo-derived 97–116 peptide of the AChR
alpha-subunit induces experimental myasthenia gravis in Lewis rat.
Ann N Y Acad Sci. 998:391–394. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
He X, Zhou S, Ji Y, Zhang Y, Lv J, Quan S,
Zhang J, Zhao X, Cui W, Li W, et al: Sorting nexin 17 increases
low-density lipoprotein receptor-related protein 4 membrane
expression: A novel mechanism of acetylcholine receptor aggregation
in myasthenia gravis. Front Immunol. 13:9160982022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang CC, Li H, Zhang M, Li XL, Yue LT,
Zhang P, Zhao Y, Wang S, Duan RN, Li YB and Duan RS: Caspase-1
inhibitor ameliorates experimental autoimmune myasthenia gravis by
innate dendric cell IL-1-IL-17 pathway. J Neuroinflammation.
12:1182015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Claussen GC, Fesenmeier JT, Hah JS, Brooks
J and Oh SJ: The accessory nerve repetitive nerve stimulation test:
A valuable second-line test in myasthenia gravis. Eur J Neurol.
2:492–497. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nie Q, Zhu L, Zhang L, Leng B and Wang H:
Astragaloside IV protects against hyperglycemia-induced vascular
endothelial dysfunction by inhibiting oxidative stress and
Calpain-1 activation. Life Sci. 232:1166622019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu YL, Zhang QZ, Wang YR, Fu LN, Han JS,
Zhang J and Wang BM: Astragaloside IV improves High-Fat
Diet-Induced hepatic steatosis in nonalcoholic fatty liver disease
rats by regulating inflammatory factors level via TLR4/NF-κB
signaling pathway. Front Pharmacol. 11:6050642020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang J, Wang HX, Zhang YJ, Yang YH, Lu ML,
Zhang J, Li ST, Zhang SP and Li G: Astragaloside IV attenuates
inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway
in isoproterenol-induced myocardial hypertrophy. J Ethnopharmacol.
150:1062–1070. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Laferriere CA and Pang DS: Review of
intraperitoneal injection of sodium pentobarbital as a method of
euthanasia in laboratory rodents. J Am Assoc Lab Anim Sci.
59:254–263. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
van der Bliek AM, Sedensky MM and Morgan
PG: Cell biology of the mitochondrion. Genetics. 207:843–871. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mansilla N, Racca S, Gras DE, Gonzalez DH
and Welchen E: The complexity of mitochondrial Complex IV: An
update of cytochrome c oxidase biogenesis in plants. Int J Mol Sci.
19:6622018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ni GX, Liang C, Wang J, Duan CQ, Wang P
and Wang YL: Astragaloside IV improves neurobehavior and promotes
hippocampal neurogenesis in MCAO rats though BDNF-TrkB signaling
pathway. Biomed Pharmacother. 130:1103532020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shi YH, Zhang XL, Ying PJ, Wu ZQ, Lin LL,
Chen W, Zheng GQ and Zhu WZ: Neuroprotective effect of
Astragaloside IV on cerebral Ischemia/Reperfusion injury rats
through Sirt1/Mapt pathway. Front Pharmacol. 12:6398982021.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yin Y, Qu H, Yang Q, Fang Z and Gao R:
Astragaloside IV alleviates Schwann cell injury in diabetic
peripheral neuropathy by regulating microRNA-155-mediated
autophagy. Phytomedicine. 92:1537492021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kuo YC, Chen IY and Rajesh R:
Astragaloside IV- and nesfatin-1-encapsulated phosphatidylserine
liposomes conjugated with wheat germ agglutinin and leptin to
activate anti-apoptotic pathway and block phosphorylated tau
protein expression for Parkinson's disease treatment. Mater Sci Eng
C Mater Biol Appl. 129:1123612021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tian Y, Jin S, Promes V, Liu X and Zhang
Y: Astragaloside IV and echinacoside benefit neuronal properties
via direct effects and through upregulation of SOD1 astrocyte
function in vitro. Naunyn Schmiedebergs Arch Pharmacol.
394:1019–1029. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Smith EF, Shaw PJ and De Vos KJ: The role
of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett.
710:1329332019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Attia M, Maurer M, Robinet M, Le Grand F,
Fadel E, Le Panse R, Butler-Browne G and Berrih-Aknin S: Muscle
satellite cells are functionally impaired in myasthenia gravis:
Consequences on muscle regeneration. Acta Neuropathol. 134:869–888.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Truffault F, de Montpreville V, Eymard B,
Sharshar T, Le Panse R and Berrih-Aknin S: Thymic germinal centers
and corticosteroids in myasthenia gravis: An immunopathological
study in 1035 cases and a critical review. Clin Rev Allergy
Immunol. 52:108–124. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Menon D and Bril V: Pharmacotherapy of
generalized myasthenia gravis with special emphasis on newer
biologicals. Drugs. 82:865–887. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Mantegazza R and Antozzi C: When
myasthenia gravis is deemed refractory: Clinical signposts and
treatment strategies. Ther Adv Neurol Disord.
11:17562856177491342018. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lorenzoni PJ, Kay CSK, Zanlorenzi MF,
Ducci RD, Werneck LC and Scola RH: Myasthenia gravis and
azathioprine treatment: Adverse events related to thiopurine
S-methyl-transferase (TPMT) polymorphisms. J Neurol Sci.
412:1167342020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Tao X, Wang W, Jing F, Wang Z, Chen Y, Wei
D and Huang X: Long-term efficacy and side effects of low-dose
tacrolimus for the treatment of Myasthenia Gravis. Neurol Sci.
38:325–330. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Stępnik K, Kukula-Koch W, Plazinski W,
Gawel K, Gaweł-Bęben K, Khurelbat D and Boguszewska-Czubara A:
Significance of astragaloside IV from the roots of astragalus
mongholicus as an acetylcholinesterase inhibitor-from the
computational and biomimetic analyses to the in vitro and in vivo
studies of safety. Int J Mol Sci. 24:91522023. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yuan F, Yang Y, Liu L, Zhou P, Zhu Y, Chai
Y, Chen K, Tang W, Huang Q and Zhang C: Research progress on the
mechanism of astragaloside IV in the treatment of asthma. Heliyon.
9:e221492023. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Rivner MH, Pasnoor M, Dimachkie MM, Barohn
RJ and Mei L: Muscle-Specific tyrosine kinase and myasthenia gravis
owing to other antibodies. Neurol Clin. 36:293–310. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Howard FM Jr, Lennon VA, Finley J,
Matsumoto J and Elveback LR: Clinical correlations of antibodies
that bind, block, or modulate human acetylcholine receptors in
myasthenia gravis. Ann N Y Acad Sci. 505:526–538. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Lindstrom JM, Seybold ME, Lennon VA,
Whittingham S and Duane DD: Antibody to acetylcholine receptor in
myasthenia gravis. Prevalence, clinical correlates, and diagnostic
value. Neurology. 26:1054–1059. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Gilhus NE, Skeie GO, Romi F, Lazaridis K,
Zisimopoulou P and Tzartos S: Myasthenia gravis-autoantibody
characteristics and their implications for therapy. Nature Rev
Neurology. 12:259–268. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Anagnostou ME and Hepple RT: Mitochondrial
mechanisms of neuromuscular junction degeneration with aging.
Cells. 9:1972020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Xiao Y, Zhang J, Shu X, Bai L, Xu W, Wang
A, Chen A, Tu WY, Wang J, Zhang K, et al: Loss of mitochondrial
protein CHCHD10 in skeletal muscle causes neuromuscular junction
impairment. Hum Mol Genet. 29:1784–1796. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Finsterer J, Oberman I and Reitner A:
Respiratory chain complex-I defect mimicking myasthenia. Metab
Brain Dis. 17:41–46. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Jang YC, Lustgarten MS, Liu Y, Muller FL,
Bhattacharya A, Liang H, Salmon AB, Brooks SV, Larkin L, Hayworth
CR, et al: Increased superoxide in vivo accelerates age-associated
muscle atrophy through mitochondrial dysfunction and neuromuscular
junction degeneration. FASEB. 24:1376–1390. 2010. View Article : Google Scholar
|
|
73
|
Holper L, Ben-Shachar D and Mann JJ:
Multivariate meta-analyses of mitochondrial complex I and IV in
major depressive disorder, bipolar disorder, schizophrenia,
Alzheimer disease, and Parkinson disease. Neuropsychopharmacology.
44:837–849. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ferreira N, Andoniou CE, Perks KL, Ermer
JA, Rudler DL, Rossetti G, Periyakaruppiah A, Wong JKY, Rackham O,
Noakes PG, et al: Murine cytomegalovirus infection exacerbates
complex IV deficiency in a model of mitochondrial disease. PLoS
Genet. 16:e10086042020. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Hatakeyama H and Goto YI: Respiratory
chain complex disorganization impairs mitochondrial and cellular
integrity: Phenotypic variation in cytochrome c oxidase deficiency.
Am J Pathol. 187:110–121. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wang XL, Feng ST, Wang ZZ, Chen NH and
Zhang Y: Role of mitophagy in mitochondrial quality control:
Mechanisms and potential implications for neurodegenerative
diseases. Pharmacol Res. 165:1054332021. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Chu CT: Mechanisms of selective autophagy
and mitophagy: Implications for neurodegenerative diseases.
Neurobiol Dis. 122:23–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Evans CS and Holzbaur ELF: Autophagy and
mitophagy in ALS. Neurobiol Dis. 122:35–40. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Carrascoso I, Sánchez-Jiménez C, Silion E,
Alcalde J and Izquierdo JM: A heterologous cell model for studying
the role of T-Cell intracellular antigen 1 in welander distal
myopathy. Mol Cell Biol. 39:e00299–18. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Wang TS, Coppens I, Saorin A, Brady NR and
Hamacher-Brady A: Endolysosomal targeting of mitochondria is
integral to BAX-Mediated mitochondrial permeabilization during
apoptosis signaling. Developmental cell. 53:627–645.e7. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yin W, Li R, Feng X and James Kang Y: The
Involvement of cytochrome c Oxidase in mitochondrial fusion in
primary cultures of neonatal rat cardiomyocytes. Cardiovasc
Toxicol. 18:365–373. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang XR, Wang C and Wang XW, Qian LX, Chi
Y, Liu SS, Liu YQ and Wang XW: The functions of caspase in whitefly
Bemisia tabaci apoptosis in response to ultraviolet irradiation.
Insect Mol Biol. 27:739–751. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Huang G, Li H and Zhang H: Abnormal
expression of mitochondrial ribosomal proteins and their encoding
genes with cell apoptosis and diseases. Int J Mol Sci. 21:88792020.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Hazafa A, Batool A, Ahmad S, Amjad M,
Chaudhry SN, Asad J, Ghuman HF, Khan HM, Naeem M and Ghani U:
Humanin: A mitochondrial-derived peptide in the treatment of
apoptosis-related diseases. Life Sci. 264:1186792021. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Bock FJ and Tait SWG: Mitochondria as
multifaceted regulators of cell death. Nat Rev Mol Cell Biol.
21:85–100. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zheng M, Kuang N, Zeng X, Wang J, Zou Y
and Fu Y: Daphnetin induces apoptosis in fibroblast-like
synoviocytes from collagen-induced arthritic rats mainly via the
mitochondrial pathway. Cytokine. 133:1551462020. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Xia ML, Xie XH, Ding JH, Du RH and Hu G:
Astragaloside IV inhibits astrocyte senescence: Implication in
Parkinson's disease. J Neuroinflammation. 17:1052020. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Yin Y, Qu H, Yang Q, Fang Z and Gao R:
Corrigendum to ‘Astragaloside IV alleviates Schwann cell injury in
diabetic peripheral neuropathy by regulating microRNA-155-mediated
autophagy’. Phytomedicine. 97:1539162022. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Lin J, Pan X, Huang C, Gu M, Chen X, Zheng
X, Shao Z, Hu S, Wang B, Lin H, et al: Dual regulation of microglia
and neurons by Astragaloside IV-mediated mTORC1 suppression
promotes functional recovery after acute spinal cord injury. J Cell
Mol Med. 24:671–685. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Li H, Xu J, Zhang Y, Hong L, He Z, Zeng Z
and Zhang L: Astragaloside IV alleviates senescence of vascular
smooth muscle cells through activating Parkin-mediated mitophagy.
Hum Cell. 35:1684–1696. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Feng M, Lv J, Zhang C, Chen D, Guo H, Tu
Y, Su L and Wang Z: Astragaloside IV protects sepsis-induced acute
kidney injury by attenuating mitochondrial dysfunction and
apoptosis in renal tubular epithelial cells. Curr Pharm Des.
28:2825–2834. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Li H, Yao C, Shi K, Zhao Y, Du J, Hu D and
Liu Z: Astragaloside IV attenuates hypoxia/reoxygenation
injury-induced apoptosis of type II alveolar epithelial cells
through miR-21-5p. Bioengineered. 12:7747–7754. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Wang F, Zhao Y, Chen S, Chen L, Sun L, Cao
M, Li C and Zhou X: Astragaloside IV alleviates ammonia-induced
apoptosis and oxidative stress in bovine mammary epithelial cells.
Int J Mol Sci. 20:6002019. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Qin S, Yin J, Huang S, Lin J, Fang Z, Zhou
Y and Huang K: Astragaloside IV protects ethanol-induced gastric
mucosal injury by preventing mitochondrial oxidative stress and the
activation of mitochondrial pathway apoptosis in rats. Front
Pharmacol. 10:8942019. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Yoshii SR and Mizushima N: Monitoring and
measuring autophagy. Int J Mol Sci. 18:18652017. View Article : Google Scholar : PubMed/NCBI
|
